Company:  MOMENTA PHARMACEUTICALS I ... (MNTA)
Form Type:  10-Q
Filing Date:  11/8/2012 
CIK:  0001235010 
Address:  675 WEST KENDALL STREET 
City, State, Zip:  CAMBRIDGE, Massachusetts 02142 
Telephone:  617 491-9700 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$11.34  
Change: 
-0.15 (-1.31%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$629.25M
Description of Business
We are a biotechnology company operating in three product areas: Complex Generics, Biosimilars and Novel Drugs. Our approach is built around a complex systems analysis platform that we use to obtain a detailed understanding of complex chemical and biologic systems, design product candidates based on this knowledge, analyze sets of biological data to evaluate the biological function of our products, and develop manufacturing processes that enable our products to be reliably produced. Our first product, developed in collaboration with Sandoz, Enoxaparin Sodium Injection, a generic version of Lovenox�, was approved in July of 2010, validating the commercial value of our platform. In the period from commercial launch through September 2011, we capitalized on the advantage of having the only generic version of Lovenox in the marketplace and recognized over $340 million in revenue from this product.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I. FINANCIAL INFORMATION
      Item 1 ...
        BALANCE SHEET
        CASH FLOW
        NOTES TO UNAUDITED, CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
      Item 2. Management's ...
      Item 4 ...
    PART II. OTHER INFORMATION
      Item 1 ...
      Item 1A ...
    SIGNATURES
  EXHIBIT 10.1
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
BROKERAGE PARTNERS